Navigation Links
Iomai Announces Year-End 2007 Financial Results and Business Progress
Date:3/6/2008

836 621

Net loss before cumulative effect of a

change in accounting principle (28,274) (31,802)

Cumulative effect of change in accounting

principle - 17

Net loss (28,274) (31,785)

Dividends on and accretion of convertible

preferred stock - (471)

Net loss available to common stockholders $(28,274) $(32,256)

Net loss available to common stockholders

per share of common stock - basic and diluted $(1.16) $(2.03)

Weighted-average number of shares of

common stock - basic and diluted 24,412,688 15,915,797

SELECTED BALANCE SHEET DATA (Unaudited)

(In thousands)

December 31,

2007 2006

`

Cash and cash equivalents and unrestricted

marketable securities $15,500 $15,336

Accounts receivable 4,011 62

Total assets 27,355 23,085

Total debt and capital lease obligations 3,655 4,759

Total liabilities 9,402 9,050

Accumulated deficit (129,062) (100,788)

Total stockholders' equity 17,953 14,035


'/>"/>
SOURCE Iomai Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Iomai to Announce Fourth Quarter and Year-End 2007 Financial Results and Host Webcast on Thursday, March 6
2. Iomai CEO to Speak at BIO CEO & Investor Forum on Feb. 12
3. Iomai to Announce Third Quarter 2007 Financial Results and Host Webcast on Tuesday, November 13
4. Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers Diarrhea Patch at Keystone Conference
5. Iomai CEO to Speak at Natixis Bleichroeder Hidden Gems Conference on Monday
6. Dragon announces new product launch; increase in annual production output capacity
7. Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve
8. China Yingxia International Announces Q4 and FY 2007 Estimates
9. Bristol-Myers Squibb Announces Dividend
10. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
11. Maxygen Announces Management Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... (PRWEB) December 19, 2014 BioPlus ... specialty pharmacies, announces the promotion of Nick Maroulis, Pharm.D. ... Specialty Pharmacy Services. , In this position, Dr. ... while also managing the directors of our multi-site pharmacies ... BioPlus since 1997 and during that time he has ...
(Date:12/19/2014)... PLEASANTON, Calif. , Dec. 19, 2014  Roche ... acquisition of Bina Technologies, Inc. (Bina), a privately ... California , USA. Bina provides a big ... next generation sequencing (NGS) data. Bina,s proprietary on-market ... translational and academic researchers to perform fast and ...
(Date:12/19/2014)... -- Decision Resources Group finds that the Latin American ... compound annual growth rate through 2023. This is primarily ... increasing adoption of dental implants. Growing aesthetic consciousness in ... demand for dental biomaterials because they can improve the ... Other key findings from Decision Resources Group,s coverage ...
(Date:12/19/2014)... Springs, FL (PRWEB) December 18, 2014 ... of the nation’s leading specialty pharmacies, has an ... serve as clinical pharmacy consultants for prescriber offices ... therapy expertise. , “We have a variety ... therapies. For example, those specializing in hepatitis C ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3
... J. Chartier and H.C. Birnboim , ... , DNA collected with Oragene works well with TaqMan ... apolipoprotein E genes were reliably , detected., ... Single-nucleotide polymorphisms (SNPs) are highly abundant, and are estimated , ...
... H.C. Birnboim , DNA Genotek, Ottawa, Ontario, Canada , ... higher DNA yields than other oral, collection methods. The median yield ... swabs may yield as little as 1.9 g of DNA. ... , The number of studies collecting genomic DNA from ...
... , DNA Genotek, Ottawa, Ontario, Canada , ... by refrigeration or freezing can add significant , costs to ... specimens to be stored for years at room temperature without DNA degradation. , ... Introduction , Large population-based ...
Cached Biology Technology:Oragene is compatible with TaqMan SNP genotyping 2Oragene is compatible with TaqMan SNP genotyping 3DNA Yield with Oragene 2DNA Stability with Oragene 2DNA Stability with Oragene 3
(Date:12/22/2014)... 2014  The 2014 Holiday Season may be ... Acuity Market Intelligence reports that the long anticipated ... Acuity forecasts that intensifying demand for smart phones, ... will drive a global market of 2.5 billion ... 2020.   According to Maxine ...
(Date:12/19/2014)... LAS VEGAS , Dec. 18, 2014   ... platform built for the post-password and Internet of Things ... additional seed funding. The venture round was led by ... Pantera Capital, Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey ... the new funding to expand its team and bring ...
(Date:12/17/2014)... 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ... robust – with the clinical data to back it ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... This release is available in German . , ... reliable testing of HIV inhibitors. This system was developed under ... Virology. At the heart of the system are cultured human ... that signal HIV infection by producing a red fluorescent protein. ...
... Age-related hearing loss (ARHL), one of the four most prevalent ... levels of folic acid, according to new research published in ... Neck Surgery . Hearing loss is a major ... between the ages of 60 and 74 dealing with the ...
... N.Y. (December 1, 2010) A new study published in ... JAMA ) and partially funded by Autism Speaks, found that ... of their cells due to dysfunctional mitochondria. These new ... dysfunction and suggest a novel way of screening for these ...
Cached Biology News:A powerful new technology to identify HIV inhibitors 2Children with autism more likely to have mitochondrial defects impacting cellular energy production 2
Amino-acids and Derivatives Rabbit Anti-conjugated L-isoleucine Polyclonal Antibody...
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
Mouse monoclonal [88B] to nicotinic Acetylcholine Receptor ( Abpromise for all tested applications)....
D4-GDI rabbit polyclonal antibody...
Biology Products: